Disease Intelligence Center · Fifth Estate · Whole-system view
IBS & Gut Barrier Dysfunction
Symptoms are mapped across diet, motility, visceral sensitivity, microbial ecology, immune activation and exposures, while red flags are routed to conventional evaluation first.
Domain weighting
Organizational emphasisiWeightings describe where this framework directs attention for this condition. They are not a measure of how much any factor caused an individual case.
Root-cause chain
Each link carries its own evidence grade- Post-infectious immune activation→Visceral hypersensitivityIB
Post-infectious IBS cohorts show persistent mucosal immune changes and altered sensation.
Relationship: Observational association
- Fermentable carbohydrate load→Bloating and painNA
Low-FODMAP trials demonstrate symptom reduction in a substantial subgroup.
Relationship: Randomized evidence
- Bacteriome and bile-acid alteration→Stool-form changeIC
Bile-acid malabsorption and microbial shifts plausibly affect transit; testing is often inconclusive.
Relationship: Mechanistic plausibility
- Stress and autonomic load→Symptom amplificationBB
Gut-directed hypnotherapy and CBT reduce symptom severity in trials.
Relationship: Randomized evidence
iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.
Fifth Estate considerations
Microbial ecologyCore Fifth Estate case: a stool organism report is classified as active infection, colonization, dysbiosis hypothesis, past exposure or incidental detection before any antimicrobial is discussed.
Go deeper
TOBIN Intelligence LibraryThe full evidence review for IBS & Gut Barrier Dysfunction: each mechanism by domain, what is established versus uncertain, related pandemics, relevant labs and how they move your scores.
Open the IBS & Gut Barrier Dysfunction evidence reviewProtocol Fusion Engine
Six lanes · evidence grade and regulatory status on every entryConventional
Guideline-based agents for IBS-C, IBS-D and pain-predominant subtypes.
Caution: Subtype-specific contraindications; review before each change.
Functional
Effective in a defined subgroup when supervised.
Caution: Avoid long-term restriction; nutrient adequacy and eating-disorder risk must be monitored.
Integrative
Reduces symptom severity with durable effects.
Caution: Requires trained practitioner.
Orthomolecular
Improves global symptoms, particularly in IBS-C.
Published range: 5–10 g
Frequency: 1–2 times daily with water
Follow-up: Bowel habit review at 4 weeks · Source: Bile-acid binding literature
Caution: Start low; worsens bloating if escalated quickly.
Traditional
Antispasmodic benefit in several trials.
Caution: Reflux aggravation; avoid in significant GERD.
Energy / Physical
Energy medicine on Tayapulse →Minimal controlled evidence.
Caution: Never a substitute for red-flag evaluation.
iLanes are presented side by side so the difference in evidence strength is visible. Nothing here is a prescription, and interactions must be reviewed with your clinician and pharmacist.
iEnergy and physical modalities in this lane are explored further with Tayapulse. Evidence grade and regulatory status still apply: these are adjuncts used only where indicated, never cures or replacements for guideline care.
Diagnostics to consider
- · Red-flag screen (bleeding, weight loss, anemia, onset over 50)
- · Celiac serology and calprotectin
- · Targeted stool studies only when justified
- · Symptom and food diary
Monitoring
- · Symptom severity score monthly
- · Dietary adequacy review during restriction
- · Reintroduction schedule after low-FODMAP phase
Prevention emphasis
- · Regular meal timing and fiber titration
- · Stress and sleep management
- · Avoid unnecessary antibiotics